机构:
Univ Bristol, Sch Clin Sci, Level 7 Bristol Royal Infirm, Bristol BS2 8HW, Avon, EnglandUniv Bristol, Sch Clin Sci, Level 7 Bristol Royal Infirm, Bristol BS2 8HW, Avon, England
Westbury, S. K.
[1
]
Mumford, A. D.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Bristol, Sch Clin Sci, Level 7 Bristol Royal Infirm, Bristol BS2 8HW, Avon, England
Bristol Haemophilia Comprehens Care Ctr, Bristol, Avon, England
West England Genom Med Ctr, Bristol, Avon, EnglandUniv Bristol, Sch Clin Sci, Level 7 Bristol Royal Infirm, Bristol BS2 8HW, Avon, England
Mumford, A. D.
[1
,2
,3
]
机构:
[1] Univ Bristol, Sch Clin Sci, Level 7 Bristol Royal Infirm, Bristol BS2 8HW, Avon, England
[2] Bristol Haemophilia Comprehens Care Ctr, Bristol, Avon, England
[3] West England Genom Med Ctr, Bristol, Avon, England
genetic diagnosis;
next-generation sequencing;
platelet function disorders;
platelet number disorders;
THROMBOCYTOPENIA;
MUTATIONS;
DEFECTS;
ELTROMBOPAG;
DISEASE;
D O I:
10.1111/hae.12964
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Genetic diagnosis in families with inherited platelet disorders (IPD) is not performed widely because of the genetic heterogeneity of this group of disorders and because in most cases, it is not possible to select single candidate genes for analysis using clinical and laboratory phenotypes. Next-generation sequencing (NGS) technology has revolutionized the scale and cost-effectiveness of genetic testing, and has emerged as a valuable tool for IPD. This review examines the potential utility of NGS as a diagnostic tool to streamline detection of causal variants in known IPD genes and as a vehicle for new gene discovery.